Atlas Trials

Effects of Doxycycline and Rifampicin on Biomarkers of Alzheimer's Disease in the Cerebrospinal Fluid

Clinical trial NCT00439166 · COMPLETED

Trial details

NCT number
NCT00439166
Sponsor
Hamilton Health Sciences Corporation
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Alzheimer's Disease
Start date
2007-02-01
Primary completion
2010-04-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.